Risperidone-associated diabetes mellitus: a pharmacovigilance study (Q35160244)

6 August 2017

Risperidone-associated diabetes mellitus: a pharmacovigilance study (English)

1 reference

6 August 2017

Elizabeth A Koller

1

1 reference

6 August 2017

James T Cross

series ordinal

2

1 reference

6 August 2017

P Murali Doraiswamy

series ordinal

3

1 reference

6 August 2017

Bruce S Schneider

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

23

1 reference

6 August 2017

6

1 reference

6 August 2017

735-744

1 reference

Risperidone: treatment response in adult and geriatric patients.

6 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Pharmacokinetic drug interaction potential of risperidone with cytochrome p450 isozymes as assessed by the dextromethorphan, the caffeine, and the mephenytoin test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Risperidone-associated new-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

1988 annual report of the American Association of Poison Control Centers National Data Collection System

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

1990 Annual report of the American Association of Poison Control Centers National Data Collection System

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

1994 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

1987 Annual report of the American Association of Poison Control Centers National Data Collection System

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

1998 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Altered ovarian function and cardiovascular risk factors in valproate-treated women

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Bodyweight gain and anticonvulsants: a comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Postmarketing surveillance and adverse drug reactions: current perspectives and future needs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Timing of new black box warnings and withdrawals for prescription medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Quetiapine-associated hyperglycemia and hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Clozapine-associated diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Olanzapine-associated diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Different effects of antipsychotic drugs on insulin release in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.6.735.32178

10.1592/PHCO.23.6.735.32178

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference